Komori
Medipal Holdings (7459) · InitiativeCited as achieved

Basic Agreement on the Acquisition of To-Shichi as a Wholly Owned Subsidiary

First written in FY2023-Q1. 2 of 5 entries say "Cited as achieved", first in FY2024-Q1. Latest entry: FY2024.

5entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023-Q1AdvancedFY2023-Q3 – FY2023Cited as achievedFY2024-Q1 – FY20242022: 120222023: 320232024: 12024
Same theme, other companies
Consolidation and revenue growth effects from making 東七 a wholly owned subsidiaryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024Cited as achievedAnnual report

    「During the current fiscal year, we made 東七株式会社 (Sasebo, Nagasaki; hereinafter, 東七) a consolidated subsidiary, and 株式会社メディスケット (Misato, Saitama; hereinafter, メディスケット) commenced full-scale operations.」

    The company cited 東七's inclusion in the consolidated results following its conversion to a wholly owned subsidiary and メディスケット's commencement of full-scale operations as factors behind the increase in revenue in FY2024.
  2. FY2024-Q1Cited as achievedAnnual report

    「東七株式会社 has been included in the scope of consolidation since the current first quarter consolidated accounting period because we acquired its shares.」

    Following the conversion to a wholly owned subsidiary on 3 April 2023, 東七 was included in the scope of consolidation from FY2024-Q1. Its inclusion in the consolidated results was also cited as a factor behind the increase in revenue.
  3. FY2023AchievedAnnual report

    「On 1 February 2023, we entered into a share exchange agreement with 東七株式会社 (Sasebo, Nagasaki), and on 3 April of the same year made 東七 a wholly owned subsidiary.」

    The conversion of 東七 into a wholly owned subsidiary was completed on 3 April 2023, following the basic agreement in July 2022 and execution of the share exchange agreement in February 2023. The company has stated its aim of strengthening distribution infrastructure in Nagasaki and Saga prefectures.
  4. FY2023-Q3AdvancedAnnual report

    「In July 2022, we entered into a basic agreement with 東七株式会社 (Sasebo, Nagasaki; hereinafter, 東七) concerning a transaction in which we would acquire all of 東七's issued shares and continued consideration and discussions. On 1 February 2023, we entered into a share exchange agreement under which we would become the wholly owning parent company and 東七 would become the wholly owned subsidiary. The effective date is scheduled for 3 April of the same year.」

    The planned conversion of 東七 into a wholly owned subsidiary progressed from the basic agreement and discussion stage in July 2022 to the execution of a share exchange agreement on 1 February 2023. The effective date was scheduled for 3 April 2023.
  5. FY2023-Q1First statedAnnual report

    「On 29 July 2022, we entered into a basic agreement with 東七株式会社 (Sasebo, Nagasaki; hereinafter, 東七) concerning a transaction in which we would acquire all of 東七's issued shares. Going forward, we plan to continue discussions and consideration with the aim of acquiring all of 東七's issued shares effective 1 April 2023.」

    On 29 July 2022, the company entered into a basic agreement to acquire all of 東七's issued shares and announced plans to hold discussions and consider the transaction with the aim of making 東七 a wholly owned subsidiary effective 1 April 2023.
Moved together

"Use of Retained Earnings and Flexible Share Repurchases" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222★123
  1. ★This thread
  2. 1Use of Retained Earnings and Flexible Share Repurchases2×
  3. 2Expansion into Digital Healthcare Through a Capital and Business Alliance with MTI2×
  4. 3New Pharmaceutical Production and Distribution Model through a Capital and Business Alliance with Nichi-Iko Pharmaceutical Co., Ltd.2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Basic Agreement on the Acquisition of To-Shichi as a Wholly Owned Subsidiary | MEDIPAL HOLDINGS CORPORATION (7459) | Komori